
✓
Open
15 Mar 2021
✓
Close
17 Mar 2021
3
Allotment
—
✓
Listing
Thu, Mar 25, 2021
Price Band
₹129 to ₹130
Issue Size
4,61,53,846 shares (agg. up to ₹600 Cr)
Lot Size
115 Shares
Listing Date
Thu, Mar 25, 2021
Latest GMP
₹40
Est. Gain
30.77%
✦ AI Insight
GMP Trend
25-03-2021₹40Est. ₹170+30.77%
24-03-2021₹65Est. ₹195+50%
23-03-2021₹60Est. ₹190+46.15%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 74.78x |
Restated Financials (₹ Cr.)
| Period Ended | 30 Sep 2020 | 31 Mar 2020 | 31 Mar 2019 | 31 Mar 2018 |
|---|---|---|---|---|
| Assets | 1,037.13 | 1,070.63 | 1,014.49 | 894.73 |
| Total Income | 814.36 | 1,538.62 | 1,574.32 | 1,396.08 |
| Profit After Tax | 45.48 | 70.21 | 72.39 | 75.70 |
| EBITDA | 86.34 | 143.71 | 158.62 | 154.41 |
| NET Worth | 471.45 | 425.96 | 448.89 | 378.37 |
| Reserves and Surplus | 427.39 | 381.90 | 399.80 | 369.31 |
| Total Borrowing | 192.18 | 158.84 | 175.33 | 215.06 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Anupam Rasayan India Ltd. | Mainboard | ₹760.00 Cr | ₹555 | null | ₹526.80 | -5.08% | ₹1,269.00 (+0.25%) |
| Chemcon Speciality Chemicals Ltd. | Mainboard | ₹318.00 Cr | ₹340 | null | ₹584.80 | +72.00% | ₹184.25 (+0.65%) |
| Rossari Biotech Ltd. | Mainboard | ₹496.25 Cr | ₹425 | 33.81 | ₹741.65 | +74.51% | ₹541.55 (+1.62%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Investment in YFCPL for part-financing itscapital expenditure requirements in relation to the setting up of the Proposed Facility | 60.40 |
| 2 | Investment in YFCPL for funding its working capital requirements of YFCPL | 37.74 |
| 3 | Funding capital expenditure requirements for expansion of our SI Manufacturing Facility | 91.06 |
| 4 | Funding working capital requirements of our Company | 35.18 |
| 5 | Purchase of plant and machinery for augmenting infrastructure development at our SI Manufacturing Facility | 12.57 |
| 6 | Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our Company and VLPL | 179.31 |
| 7 | General corporate purposes | 63.73 |
About Laxmi Organic Industries IPO
Incorporated in 1989, Laxmi Organic Industries Ltd is a specialty chemical manufacturer that operates in 2 business segments; Acetyl Intermediates (AI) and Specialty Intermediates (SI). It is the leading manufacturer of ethyl acetate with over 30% market share in the Indian ethyl acetate market and the only manufacturer of diketene derivatives in India. Its AI segment includes ethyl acetate, acetaldehyde, fuel-grade ethanol, and other proprietary solvents whereas the SI segment includes ketene, diketene derivatives namely esters, acetic anhydride, arylides, amides, and other chemicals. Its products are being used in various industries like pharmaceuticals, agrochemicals, inks & coatings, dyes & pigments, paints, printing & packaging, etc. Alembic Pharmaceuticals Limited, Laurus Labs Limited, Granules India Limited, Hetero Labs Limited, Heubach Colour Private Limited, Hubergroup India Private Limited, Huhtamaki India Limited, Macleods Pharmaceuticals Private Limited, Suven Pharmaceuticals Limited, Colourtex Industries Private Limited, and UPL Limited are some of its customers. The company has a global footprint with customers in 30 countries including but not restricted to China, Ru
Contact Details
Laxmi Organic Industries Ltd. AddressA-22/2/3, MIDCMahad, RaigadMahad, Maharashtra, 402309+91-2145-232424investors@laxmi.comVisit Website